scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00128958 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/bf00128958 |
P698 | PubMed publication ID | 8871536 |
P2093 | author name string | V W Yong | |
J H Uhm | |||
J G Villemure | |||
N P Dooley | |||
P2860 | cites work | Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. | Q55484376 |
Membrane proteases in focus | Q59052655 | ||
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases | Q68190931 | ||
The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture | Q68493823 | ||
Gelatinases of murine metastatic tumor cells | Q69325885 | ||
Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta | Q69326294 | ||
Effects of 12-O-tetradecanoylphorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells | Q69988354 | ||
Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma | Q72253840 | ||
Antibody to rabbit macrophage type V collagenase/gelatinase and its use to further characterize the enzyme | Q72389147 | ||
Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells | Q72785644 | ||
Regulation of tissue inhibitor of matrix metalloproteinase expression | Q72853147 | ||
A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 | ||
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene | Q29618347 | ||
Adhesion molecules and malignant gliomas: implications for tumorigenesis | Q36006737 | ||
Plasminogen activator and collagenase production by cultured capillary endothelial cells | Q36209178 | ||
Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease | Q36220992 | ||
Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells | Q36752257 | ||
Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis | Q37483919 | ||
Protease inhibitors implicate metalloendoprotease in synaptic transmission at the mammalian neuromuscular junction | Q37616838 | ||
Brain tumor epidemiology, growth, and invasion | Q37848135 | ||
Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. | Q38190315 | ||
Biochemical interactions of tumor cells with the basement membrane | Q39503917 | ||
Matrix metalloproteinase gene expression | Q40642356 | ||
Metalloproteinase domain structure, cellular invasion and metastasis | Q40764344 | ||
Cell-adhesion molecules and metalloproteinases: a linked role in tumour cell invasiveness | Q40764352 | ||
The potential of protein kinase C as a target for anticancer treatment | Q40815216 | ||
Biology and biochemistry of proteinases in tumor invasion. | Q40868702 | ||
Protein kinase C: a novel target for inhibiting gastric cancer cell invasion | Q41085730 | ||
Possible involvement of Ca2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells | Q41260804 | ||
Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. | Q41328328 | ||
Expression of timp-1, timp-2, 72-kda and 92-kda type-iv collagenase transcripts in human astrocytoma cell-lines - correlation with astrocytoma cell invasiveness | Q41351721 | ||
Monoclonal antibodies to human MMP-9. | Q41442903 | ||
Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate | Q41503011 | ||
TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. | Q41509771 | ||
Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen | Q41528688 | ||
The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. | Q41542149 | ||
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model | Q41586807 | ||
Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C | Q41600478 | ||
The effect of tumor necrosis factor-α on human malignant glial cells | Q41633889 | ||
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines | Q41651909 | ||
Tumor Cell Invasion Inhibited by TIMP-2 | Q41679983 | ||
Inhibition of protein kinase C by calphostin C is light-dependent | Q41687741 | ||
A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells | Q41691814 | ||
Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine | Q41714472 | ||
Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells | Q41737236 | ||
Differential proliferative response of human and mouse astrocytes to gamma-interferon | Q42457396 | ||
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro | Q42468714 | ||
A rapid in vitro assay for quantitating the invasive potential of tumor cells | Q42807739 | ||
Cultured human glial and glioma cells. | Q42823441 | ||
Induction of proto-oncogene JUN/AP-1 by serum and TPA. | Q43487125 | ||
Regulation of collagenase and collagenase mRNA production in early- and late-passage human diploid fibroblasts | Q44234904 | ||
Characterization and Identification of Proteinases and Proteinase Inhibitors Synthesized by Temporomandibular Joint Disc Cells | Q46352323 | ||
Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors | Q48091109 | ||
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma | Q48241087 | ||
Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors | Q48284379 | ||
Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo | Q48315375 | ||
Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. | Q48376448 | ||
Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity | Q48376454 | ||
Serum proteolytic activity during the growth of C6 astrocytoma | Q48428986 | ||
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. | Q54425576 | ||
Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. | Q55481909 | ||
P433 | issue | 5 | |
P304 | page(s) | 421-433 | |
P577 | publication date | 1996-10-01 | |
P1433 | published in | Clinical & Experimental Metastasis | Q13470030 |
P1476 | title | Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. | |
P478 | volume | 14 |
Q38009800 | A complete compilation of matrix metalloproteinase expression in human malignant gliomas. |
Q45009039 | Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP. |
Q40980125 | Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential |
Q36509566 | Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide |
Q39817583 | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas |
Q33743513 | Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures. |
Q36715291 | Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomas |
Q41991420 | Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas |
Q40830443 | Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells |
Q40360371 | Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. |
Q34332239 | Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury |
Q40645479 | Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. |
Q42048997 | Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors |
Q55475249 | Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. |
Q55475897 | Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate. |
Q40979862 | Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. |
Q24649857 | Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas |
Q55475300 | Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. |
Q32061182 | HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors |
Q28206393 | Hyaluronate receptors mediating glioma cell migration and proliferation |
Q48457559 | Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. |
Q39938155 | Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix |
Q42475272 | Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity |
Q41728604 | Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes |
Q55463274 | Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair. |
Q41719486 | Matrix metalloproteinases and diseases of the CNS. |
Q38151704 | Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders |
Q36255730 | Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter |
Q34444283 | Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion |
Q34297141 | Metalloproteinases in biology and pathology of the nervous system. |
Q34108050 | Multi-agent cytostatic treatment of 'low-grade' gliomas |
Q48561135 | Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. |
Q42525071 | PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. |
Q33760250 | Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis |
Q34361140 | Process extension and myelin sheet formation in maturing oligodendrocytes |
Q34627812 | Proteases and the biology of glioma invasion |
Q47994379 | Protein kinase C isoforms in human aortic smooth muscle cells |
Q36741102 | Regulation of C6 glioma cell migration by thymol. |
Q40810854 | Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades |
Q38411011 | Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome |
Q37069961 | Stictamides A-C, MMP12 inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid subunits |
Q34461935 | Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells |
Q45881488 | Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. |
Q40653941 | Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease–substrate interaction |
Q37858940 | The brain tumor microenvironment. |
Q37989468 | The brain tumor microenvironment. |
Q33302115 | The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion |
Q54652595 | The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. |
Q55475425 | The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells. |
Q37780433 | The perivascular niche microenvironment in brain tumor progression |
Q36181275 | The potential use of MMP inhibitors to treat CNS diseases |
Q36328452 | The role of matrix metalloproteinases in the morphogenesis of the cerebellar cortex |
Q55476472 | The role of protein kinase Calpha in U-87 glioma invasion. |
Q52573380 | The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. |
Q44070484 | Ultrasensitive dual-channel detection of matrix metalloproteinase-2 in human serum using gold-quantum dot core-satellite nanoprobes |
Q58698576 | miR-361-5p inhibits glioma migration and invasion by targeting SND1 |
Q38314591 | p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription. |
Search more.